Exanthema - 21 Studies Found
| Completed |
: Severe Cutaneous Adverse Reactions in Thailand :
|
| Completed |
: Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases :
|
| Completed |
: Histological Characterization and Differentiation of Rash From Other Epidermal Growth Factor Receptor (EGFR) Inhibitors : Skin Rash : 2008-07-01 : Procedure: Skin Biopsy of Skin Rash Secondary to EGFRI Use Patients who were treated with lapatinib, cet |
| Withdrawn |
: Study of Acitretin to Treat Skin Rash Caused by Erlotinib (a Chemotherapy Drug) : Skin Rash : 2011-02-15 : Drug: Acitretin Acitretin 10 mg by mouth daily Other |
| Completed |
: Prevalence of Replication of Human Herpes Virus 6 (HHV6) in Blood and Skin During Exanthemia, in Patients With Hemopathy. Is There a Correlation With the Etiology of the Exanthema? :
: 2017-03-31 : Other: Measurement of the prevalence of the positivity of cutaneous HHV6 quantitative PCR in the cohort studied. |
| Completed |
: A Study of Topical Steroids as Preemptive Therapy for EGFR Inhibitor-Induced Papulopustular Eruption :
|
| Terminated |
: Vitamin D Supplementation in Polymorphic Light Eruption : Polymorphic Light Eruption : 2012-04-26 :
|
| Completed |
: Calcipotriol and Polymorphic Light Eruption : Polymorphic Light Eruption : 2009-03-27 : Drug: Calcipotriol-containing cream Topical treatment twice a day for 7 days |
| Completed |
: Sunscreen and After-sun-lotion Protection in Polymorphic Light Eruption : Polymorphic Light Eruption : 2007-10-24 :
|
| Completed |
: Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib) :
: 2013-05-31 : Drug: Tetracycline The experimental group will receive tetracycline 250mg every 12 hours for 1 month the |